Malaysiakini
ENBM中文TA
Sign In
Subscribe
  • LifetimeACTIVEINACTIVEEXPIRED
  • Registered on:Renews on:Expires on:
    ACTIVEINACTIVEEXPIRED
  • Subscribe
  • Renew
  • Extend Subscription
  • Settings
  • Contact Support
  • Sign Out
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
Malaysiakini
user
Sign In
Subscribe
ENBM中文TA
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
ENBM中文TA

      ANNOUNCEMENT

      He was the sole candidate proposed for the post during a state committee meeting.

      He was the sole candidate proposed for the post during a state committee meeting.

      China's Clover says its Covid-19 vaccine candidate shows immune response in mice
      Malaysiakini
      World
      China's Clover says its Covid-19 vaccine candidate shows immune response in mice

      China's Clover says its Covid-19 vaccine candidate shows immune response in mice

      ReutersPublished: May 18, 2021 5:22 AM

      Chinese biotechnology company Clover Biopharmaceuticals said on Tuesday the modified version of its Covid-19 vaccine candidate showed a strong immune response against the original strain of the virus and some variants during animal testing.

      Clover said in a statement its vaccine candidate demonstrated a "neutralisation" against the South African, Brazilian and UK variants among mice.

      The company is testing...

      Chinese firm's Covid-19 drug claims draw skepticism

      Chinese firm's Covid-19 drug claims draw skepticism

      US wants Covid-19 vaccine patent waiver to benefit world, not boost China biotech

      US wants Covid-19 vaccine patent waiver to benefit world, not boost China biotech

      China trials mixing of Covid vaccines from CanSinoBIO, Zhifei Longcom

      China trials mixing of Covid vaccines from CanSinoBIO, Zhifei Longcom

      China considering mixing Covid-19 vaccines to boost protection rate

      China considering mixing Covid-19 vaccines to boost protection rate

      • comments0
      • facebook
      • whatsapp
      • x
      • comments0
      • facebook
      • whatsapp
      • x
      Related reports4

      Chinese firm's Covid-19 drug claims draw skepticism

      15-05-2021

      US wants Covid-19 vaccine patent waiver to benefit world, not boost China biotech

      09-05-2021

      China trials mixing of Covid vaccines from CanSinoBIO, Zhifei Longcom

      19-04-2021

      China considering mixing Covid-19 vaccines to boost protection rate

      12-04-2021
      View Comments0

      Comments0

      By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

      Do's and don'ts when posting comments in Malaysiakini

      TERMS & CONDITIONS

      Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

      REPORT VIOLATORS

      Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

      NOTICE

      Our commenting system is still under development. We have taken note of feedback provided.

      Subscriber-only space:

      Are you a subscriber?

      Sign In

      Not yet a subscriber?

      Subscribe

      3200 characters remaining

      Pending comments0

      Are you sure you want to delete this comment?

      This action cannot be undone.

      Report this comment

      500 characters remaining
      mk-logo
      • whatsapp
      • telegram
      • youtube
      • facebook
      • x
      • instagram
      • tiktok
      • linkedin
      • About Us
      • Our Team
      • Privacy Policy
      • Terms of Service
      • Advertise with Us
      • Careers
      • Archive
      • Digital Network
      • KiniTV
      • FG Media
      • RSS Feeds
      • News
      • Opinion
      • Letters
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+6017-323 0707
      envelopesubscribe@malaysiakini.com
      • Advertising
      • advertise@malaysiakini.com
      • advertise@fgmedia.my
      Mkini Dotcom Sdn Bhd
      (199901014818 / 489718-U)No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+603-7770 0017
      envelopesubscribe@malaysiakini.com
      @Kini
      No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor